09.01.2017
- Actelion and Johnson & Johnson may be edging closer to a deal that would give the US healthcare giant at least a major chunk of the Swiss biotech firm, according to the Zurich...
29.12.2016
- US healthcare company Johnson & Johnson (J&J) is negotiating a deal to acquire Actelion that would see its commercial portfolio separated from its R&D assets, according to news...
22.12.2016
- After US healthcare company Johnson & Johnson bowed out of the race to strike a deal with Swiss biotech-pharmaceuticals company Actelion, and Sanofi was reported to have launched...
15.12.2016
- Johnson & Johnson has withdrawn from the running for Actelion Pharmaceuticals, leaving the path clear for another buyer, which multiple reports say is Sanofi. The US healthcare...
07.12.2016
- French drugs major Sanofi is weighing a rival offer to Johnson & Johnson’s recent bid for Swiss pharmaceuticals and biotech firm Actelion, the news agency Bloomberg has reported...
30.11.2016
- The splash-making news that Swiss pharmaceuticals and biotechnology firm Actelion is holding preliminary talks with major US healthcare company Johnson & Johnson (J&J) about a...
29.11.2016
- Major US healthcare company Johnson & Johnson (J&J) is holding preliminary talks with Swiss pharmaceuticals and biotechnology firm Actelion about a potential takeover. An...
11.07.2013
- As activist investors launch more high profile corporate battles in the United States, in Europe they are eschewing public hectoring for private talks. Aggressive activism has had...
